AcelRx Pharmaceuticals logo
AcelRx Pharmaceuticals ACRX
$ 0.86 7.5%

Квартальный отчет 2024-Q3
добавлен 13.11.2024

report update icon

AcelRx Pharmaceuticals Мультипликаторы 2011-2025 | ACRX

Мультипликаторы по годам AcelRx Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.7 0.1 -0.1 -4.6 -2.6 -3.0 -1.8 -2.7 -6.6 -8.7 -19.9 -3.4 -2.3

P/S

18.8 2.7 1.0 34.6 59.5 66.8 11.4 6.8 8.3 55.8 15.8 47.3 43.5

EPS

-1.3 5.7 -5.9 -0.5 -0.7 -0.8 -1.1 -0.9 -0.6 -0.8 -0.6 -1.5 -1.2

EV (Enterprise Value)

12.8 млн 15.1 млн 109 млн 282 млн 254 млн 172 млн 151 млн 143 млн 147 млн 271 млн 414 млн 96 млн 62.2 млн

EBITDA per Share

-1.16 -3.2 -5.67 -0.459 -0.663 -0.602 -0.788 -0.66 -0.389 -0.847 -0.153 -1.32 -1.09

EV/EBITDA

-3.0 -4.7 -2.8 -1.9 -1.6 -2.0 -4.2 -7.0 -64.5 -2.8 -3.1

PEG

-0.0 0.0 -0.0 -0.16 -0.15 -0.12 0.11 0.04 -0.23 0.29 -0.33 0.11 -0.02

P/B

0.9 0.2 -0.1 -3.4 -3.3 33.8 -2.5 -22.1 4.8 6.2 6.4 3.3 2.7

P/CF

-0.7 -0.2 -0.1 -4.6 -2.5 -4.8 -2.8 -3.6 -7.5 -7.3 -123.4 -4.5 -2.7

ROE %

-130.43 218.92 97.79 72.43 128.54 -1108.61 141.08 808.64 -73.68 -71.49 -32.02 -98.57 -115.07

ROA %

-90.20 100.56 -45.06 -60.91 -58.28 -39.12 -68.18 -43.16 -19.09 -38.58 -21.29 -51.71 -49.22

ROCE %

-119.74 -115.98 100.20 -84.18 -69.72 -34.15 -62.50 -35.59 -16.69 -51.78 -6.46 -59.20 -58.66

Current Ratio

3.2 1.8 0.7 2.7 5.3 6.8 4.6 8.7 9.3 5.6 15.2 4.3 4.9

DSO

- 16.5 51.5 42.8 82.9 68.0 70.0 122.7 62.3 - - - -

DIO

- - 133.1 98.4 176.7 78.4 32.7 63.8 96.1 - - - -

DPO

- - 236.2 165.6 92.2 190.0 48.8 46.2 321.9 - - - -

Операционный цикл

- 16.5 184.6 141.2 259.6 146.4 102.7 186.5 158.4 - - - -

Финансовый цикл

- 16.5 -51.6 -24.4 167.4 -43.6 54.0 140.3 -163.5 - - - -
P/E
P/S
EV/EBITDA
PEG
P/B
P/CF
ROE %
ROA %
ROCE %
Current Ratio
DSO
DIO
DPO
202320232022202220212021202020202019201920182018201720172016201620152015201420142013201320122012201120111000 1000 500 500 0 0 -500 -500 -1000 -1000 -1500 -1500
Download SVG
Download PNG
Download CSV

Все данные представлены в валюте USD

Мультипликаторы поквартально AcelRx Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.13 -0.15 -0.16 - -0.08 -0.4 -0.75 - -0.94 8.58 -1.19 - -1.4 -0.08 -0.08 - -0.1 -0.08 -0.2 -0.18 -0.16 -0.16 -0.17 -0.18 -0.21 -0.2 -0.23 -0.2 -0.28 -0.29 -0.34 -0.21 -0.25 -0.24 -0.24 -0.24 0.11 -0.2 -0.23 -320 20 -240 -220 0.41 -0.26 -0.47 -0.34 -0.41 -0.38 -0.35 -0.36 -0.33 -0.3 -0.25 -0.3

EBITDA per Share

- - - - - - -0.47 - -0.72 -1.73 -0.03 - -1.19 -0.08 -0.08 - -0.09 -0.07 -0.19 - -0.16 -0.16 -0.15 - -0.15 -0.13 -0.16 - -0.16 -0.2 -0.26 - -0.14 -0.16 -0.18 - 0.19 -0.16 -0.25 - -0.11 0.01 - - 0.01 0.01 - - 0.02 0.02 0.01 - 0.02 0.01 0.01

ROE %

-96.46 -69.09 -80.98 -106.60 -131.40 -148.78 106.38 211.08 230.54 274.80 88.97 79.63 95.65 92.20 76.68 56.43 91.26 105.98 124.09 128.54 -201.55 -525.21 -803.03 -1108.61 -786.26 -457.69 -174.07 141.08 295.42 473.42 645.48 808.64 595.38 397.04 162.35 -73.68 -71.45 -85.32 -81.12 -71.49 -17.58 -34.04 -35.22 -32.02 -87.40 -97.73 -95.14 -98.57 -103.97 -111.59 -117.60 -115.07 -32.98 -27.27 -18.34

ROA %

-50.93 -40.81 -50.07 -61.50 -75.47 -83.61 66.93 99.86 88.27 90.65 -47.61 -34.22 -47.69 -49.57 -47.16 -47.46 -63.24 -63.71 -67.33 -58.28 -52.91 -49.31 -44.47 -39.12 -41.78 -48.67 -57.21 -68.18 -64.77 -58.95 -52.76 -43.16 -41.73 -26.36 -22.23 -19.09 -26.83 -30.02 -35.29 -38.59 -6.45 -17.21 -20.83 -21.29 -53.75 -57.06 -52.36 -51.71 -51.01 -51.81 -52.33 -49.22 -14.11 -11.66 -7.85

ROCE %

- - -37.41 -74.82 -99.18 -86.13 -127.08 -52.42 -32.35 12.08 80.86 81.37 97.58 93.72 78.15 56.90 89.57 106.04 126.04 94.68 -124.65 -376.66 -577.10 -581.94 -557.67 -314.07 -118.66 84.57 234.00 359.15 487.86 465.04 486.49 358.52 178.06 -37.50 -48.37 -80.69 -56.16 -10.86 -10.86 - - - - - - - - - - - - - -

Current Ratio

1.9 2.0 2.3 3.2 4.7 2.4 2.2 1.9 2.3 2.4 0.7 0.7 0.6 0.7 0.8 0.5 0.5 0.5 0.5 0.7 0.7 0.7 0.7 1.0 1.0 1.0 1.0 0.7 0.7 0.7 0.7 0.9 0.9 0.9 0.9 1.4 1.4 1.4 1.4 2.2 2.2 2.2 2.2 3.0 3.0 3.0 3.0 2.1 2.1 2.1 2.1 1.8 1.8 1.8 1.8

DSO

- - - - - - - - 78.8 43.9 35.5 - 6.3 78.5 115.5 - 42.4 19.8 126.1 83.0 64.8 41.9 82.8 7.3 11.9 5.5 210.4 189.0 94.1 52.6 108.1 82.7 158.1 117.5 137.5 173.3 19.4 155.8 828.3 - - - - - - - - - - - - - - - -

DIO

- - - - - - - - 142.3 101.3 125.5 - 303.4 122.0 133.6 - 80.2 108.3 148.6 - 140.0 166.1 153.9 - 89.1 104.0 74.1 - 43.0 24.6 34.4 - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - 353.1 266.4 281.4 - 433.3 227.1 262.0 - 134.9 182.3 134.6 - 73.1 86.7 140.6 - 215.9 252.2 143.1 - 64.0 36.7 33.0 - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

- - - - - - - - 221.2 145.2 161.0 - 309.7 200.5 249.0 - 122.5 128.1 274.7 83.0 204.8 208.0 236.7 7.3 100.9 109.5 284.6 189.0 137.1 77.2 142.5 82.7 158.1 117.5 137.5 173.3 19.4 155.8 828.3 - - - - - - - - - - - - - - - -

Финансовый цикл

- - - - - - - - -131.9 -121.2 -120.5 - -123.6 -26.5 -13.0 - -12.4 -54.2 140.1 83.0 131.8 121.3 96.1 7.3 -115.0 -142.7 141.5 189.0 73.0 40.5 109.5 82.7 158.1 117.5 137.5 173.3 19.4 155.8 828.3 - - - - - - - - - - - - - - - -

Все данные представлены в валюте USD